Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

5-BrdU

🥰Excellent
Catalog No. T6794Cas No. 59-14-3
Alias BUdR, Broxuridine, Bromodeoxyuridine, BRDU, 5-bromo-2'-deoxyuridine

5-BrdU (Broxuridine) is a nucleoside analogue. 5-BrdU is used to detect proliferating cells and compete with thymidine for incorporation into DNA.

5-BrdU

5-BrdU

🥰Excellent
Purity: 99.87%
Catalog No. T6794Alias BUdR, Broxuridine, Bromodeoxyuridine, BRDU, 5-bromo-2'-deoxyuridineCas No. 59-14-3
5-BrdU (Broxuridine) is a nucleoside analogue. 5-BrdU is used to detect proliferating cells and compete with thymidine for incorporation into DNA.
Pack SizePriceAvailabilityQuantity
200 mg$34In Stock
500 mg$52In Stock
1 g$85In Stock
2 g$125In Stock
1 mL x 10 mM (in DMSO)$29In Stock
Add to Cart
Add to Quotation
Bulk & Custom
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
View More

Batch Information

Select Batch
Purity:99.87%
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
5-BrdU (Broxuridine) is a nucleoside analogue. 5-BrdU is used to detect proliferating cells and compete with thymidine for incorporation into DNA.
Targets&IC50
T24 cells (24 h):47 μM, HepG2 cells (24 h):11 μM, HepG2 cells:7.8 μM, L5178Y cells:20 μM, T24 cells (48 h):17 μM
In vitro
METHODS: Mouse neural precursor cells were treated with 5-BrdU, and the cell proliferation activity was detected by MTT.
RESULTS: The EC50 value of the anti-proliferation activity of 5-BrdU was 2.045μM. [1]
METHODS: L5178Y mouse leukemia cells were treated with 5-BrdU, and the growth inhibition of the cells was determined by growth inhibition.
RESULTS: In L5178Y mouse leukemia cells, the IC50 values of 5-BrdU were 20μM (determined by [14C] leucine incorporation) and 26μM (determined by [14C] thymidine incorporation), respectively. [2]
In vivo
METHODS: To study the anti-tumor activity of 5-BrdU, 5-BrdU was intraperitoneally injected (300 mg/kg) or orally administered (0.8 mg/mL) in the rat glioma RG2 tumor model.
RESULTS: 5-BrdU significantly slowed down the progression of the tumor. [3]
METHODS: To study the effect of exposure during the embryonic period on the cerebellar neuroepithelium of mice, pregnant rats were injected with different doses (25-300 µg/g) of 5-BrdU at a single time on the 13th day of the embryo.
RESULTS: Low doses (25-75 µg/g) of 5-BrdU did not change the proliferation behavior of cerebellar neuroepithelial cells, while high doses (100-300 µg/g) led to a decrease in related proliferation parameters, among which the effect of the 300 µg/g dose was the most significant. [4]
METHODS: To study the effect of 5-BrdU on neuroblasts in the granular layer outside the cerebellum of mice, different doses (50-300 µg/g) of 5-BrdU were injected once on the 9th day after the birth of mice.
RESULTS: Different doses of 5-BrdU can affect the duration of each stage of the cell cycle and the completion time of the entire cell cycle. [4]
METHODS: To investigate the effect of 5-BrdU on neurogenesis in the hippocampal dentate gyrus of adult rats, adult rats were treated with cumulative doses of 5-BrdU (40, 240 or 460 mg/kg).
RESULTS: 5-BrdU did not reduce cell proliferation or the number of immature neurons in the dentate gyrus of the hippocampus. [5]
Kinase Assay
Assays are run in the presence of 100 μM ATP using 10 μM of substrate. 30 μL PROTEIN-MIX in 25% DMSO and incubated for 15 min at room temperature. 10 μL PEPTIDE-MIX is added, the mixture is incubated for 60 min at RT and stopped by adding 180 μL 6.4% TCA (final concentration: 5%). Incorporated phosphate is measured in a scintillation counter and IC50 values are calculated using a sigmoidal curve analysis program with variable hill slope[1].
Cell Research
Cultures are initially plated at 2000 cells/cm2 and are quantified with a Z2 Coulter Counter. RG2 rat glioma cells are treated once with 0, 1, 10, or 50 μM BrdU for 24 hours, and cumulative growth curves were obtained over 18 days. Control and treated cells are quantified and replated at equal densities on days 5, 12, and 18 after treatment.(Only for Reference)
SynonymsBUdR, Broxuridine, Bromodeoxyuridine, BRDU, 5-bromo-2'-deoxyuridine
Chemical Properties
Molecular Weight307.1
FormulaC9H11BrN2O5
Cas No.59-14-3
SmilesO=C1N([C@@H]2O[C@H](CO)[C@@H](O)C2)C=C(Br)C(=O)N1
Relative Density.1.905 g/cm3
Storage & Solubility Information
Storagekeep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
Ethanol: 2 mg/mL (6.51 mM), Sonication is recommended.
H2O: 15.4 mg/mL (50.15 mM), Sonication is recommended.
DMSO: 242.5 mg/mL (789.65 mM), Sonication is recommended.
Solution Preparation Table
Ethanol/H2O/DMSO
1mg5mg10mg50mg
1 mM3.2563 mL16.2813 mL32.5627 mL162.8134 mL
5 mM0.6513 mL3.2563 mL6.5125 mL32.5627 mL
H2O/DMSO
1mg5mg10mg50mg
10 mM0.3256 mL1.6281 mL3.2563 mL16.2813 mL
20 mM0.1628 mL0.8141 mL1.6281 mL8.1407 mL
50 mM0.0651 mL0.3256 mL0.6513 mL3.2563 mL
DMSO
1mg5mg10mg50mg
100 mM0.0326 mL0.1628 mL0.3256 mL1.6281 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Sci Citations

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy 5-BrdU | purchase 5-BrdU | 5-BrdU cost | order 5-BrdU | 5-BrdU chemical structure | 5-BrdU in vivo | 5-BrdU in vitro | 5-BrdU formula | 5-BrdU molecular weight